The rising interest in GLP-1 agonists for diabetes has sparked a debate about application forms : transdermal systems versus tablets . Usually , GLP-1 treatments were solely available in tablet form, but https://ihannauylx266899.qowap.com/99999470/glp-1-skin-applications-vs-oral-medications-is-right-for-the-patient